How to appeal a Cigna pediatric oncology denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for pediatric oncology

Cited policy: Cigna coverage policy — Genetic Testing for Hereditary Cancer Susceptibility

Includes pediatric syndromes Li-Fraumeni / RB1 / NF1 / DICER1 / SMARCB1 / WT1 with personal or family history meeting criteria.

How Cigna denies pediatric oncology — and how to counter it

Where Cigna pushes back: 1) Insufficient family history; 2) Screening not medically necessary; 3) Fertility preservation cosmetic.

Counter-arguments that hold up: NCCN + ASCO + AAP-Section on Hematology/Oncology recommend germline testing in pediatric cancer per syndrome-specific criteria (adrenocortical / bilateral retinoblastoma / Wilms with overgrowth / rhabdoid). Zhang NEJM 2015 — 8.5% pediatric cancer patients have pathogenic germline variants. Results CHANGE surveillance + sibling screening + treatment selection (avoid radiation in TP53 carriers). Fertility preservation: ASCO Oktay JCO 2018/2023 + ASRM 2019 standard-of-care prior to gonadotoxic therapy. State mandates: NY/CA/IL/CT/NJ/RI/MD/NH/DE/CO/UT/MA.

What Cigna typically denies for pediatric oncology

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For pediatric oncology, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the pediatric oncology treatments most often flagged for prior auth, step therapy, or medical necessity review:

• COG trial enrollment
• CAR-T (Kymriah)
• Proton therapy
• Pediatric immunotherapy
• Targeted therapy
• ALL chemo regimen

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.